Dynavax Technologies Corp(DVAX)
10.93
Change: 0.40 (▲ 3.65%)
As of Tue 12/20/2022 11:08 AM% Of Value
Growth
Value Per Share
:
:
:
-651.65
844.00
8.8800 (as of 19/12/2022)
Fundamentals Data
| Open | 11.25 | Dividend | 26 |
| Close Price | 10.93 | DivYield | 0 % |
| High | 11.33 | Growth | 392.8 M |
| Low | 10.8 | Growth% | 844.00 |
| P/e | -3.846 | Volume | 1.6 M |
| P/b | -3.01 | Market Capital | 1.2 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 11.79 (as of 20/12/2022) | 50 Days Moving Average Percentage | -5.7829596412556 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 327,000.0 | 8.1 M | 35.2 M | 46.5 M | 439.4 M |
| Cap Spending | -669,000.0 | -4.1 M | -22.4 M | 2.7 M | -8.4 M |
| Operating Expenses | 96.3 M | 139.7 M | 150.6 M | 101.0 M | 131.3 M |
| Operating Cash Flow | -96.0 M | -153.3 M | -134.8 M | -68.3 M | 134.4 M |
| Free Cash Flow | -78.1 M | -135.4 M | -143.6 M | -89.4 M | 327.0 M |
| Free Cash Flow Per Share | -1.486 | -2.173 | -1.995 | -0.888 | 2.813 |
| Total liabilities | 0.0 | 100.8 M | 216.4 M | 214.6 M | 254.8 M |
| Total cash | 27.2 M | 49.9 M | 40.1 M | 32.3 M | 436.4 M |
| ROE% | -0.593 | -1.39 | -6.161 | -1.519 | 0.61 |
| Outstanding Shares | 61.6 M | 63.9 M | 86.1 M | 113.2 M | 124.9 M |
| P/E | -11.668 | -3.846 | -1.698 | -12.283 | 21.229 |
| P/S | 3395.285 | 74.551 | 7.513 | 19.853 | 3.485 |
| Revenue USD | 327,000.0 | 8.1 M | 35.2 M | 46.5 M | 439.4 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|